Table 2.
Univariate Logistic Regression Analysis of Revascularization Based on Preoperative Data in the Training Cohort
| Variables | OR (95% CI) | P-value |
|---|---|---|
| Follow-up time, months | 1.02(1.00–1.03) | <0.05 |
| Age, years | 1.00(0.98–1.02) | 0.707 |
| Sex, male vs female | 1.08(0.61–1.90) | 0.781 |
| DM, yes vs no | 2.51(1.54–4.09) | <0.001 |
| Hypertension, yes vs no | 0.92(0.64–1.32) | 0.669 |
| Smoke, yes vs no | 1.31(0.75–2.33) | 0.337 |
| Drink, yes vs no | 0.83(0.47–1.39) | 0.479 |
| CHD, yes vs no | 1.52(0.33–7.01) | 0.584 |
| MI, yes vs no | 0.58(0.03–0.12) | 0.727 |
| TIA, yes vs no | 0.88(0.47–1.61) | 0.684 |
| FBG, mmol/L | 1.02(0.89–1.16) | 0.812 |
| Glycosylated hemoglobin, % | 0.84(0.68–1.04) | 0.111 |
| SCr, umol/L | 0.98(0.97–1.00) | <0.01 |
| SUA, umol/L | 1.00(1.002–1.007) | <0.001 |
| TC, mmol/L | 0.78(0.53–1.14) | 0.204 |
| TC2, mmol/L | 0.69(0.44–1.04) | 0.081 |
| Triglyceride, mmol/L | 0.98(0.77–1.24) | 0.871 |
| Triglyceride2, mmol/L | 1.24(0.94–1.62) | 0.121 |
| HDL-C, mmol/L | 1.00(0.49–2.07) | 0.98 |
| HDL-C2, mmol/L | 0.77(0.35–1.67) | 0.501 |
| LDL-C, mmol/L | 0.99(0.63–1.56) | 0.975 |
| LDL-C2, mmol/L | 2.22(1.40–3.66) | <0.001 |
| Lp(a), mg/L | 1.00(1.001–1.003) | <0.001 |
| WBC, ×109/L | 0.69(0.35–1.28) | 0.253 |
| Neutrophile granulocyte, ×109/L | 1.34(0.68–2.80) | 0.407 |
| Lymphocyte, ×109/L | 1.81(0.83–4.14) | 0.147 |
| Hemoglobin, g/L | 1.00(0.997–1.008) | 0.499 |
| NLR, % | 1.01(0.84–1.19) | 0.906 |
| LDH, U/L | 1.00(0.9835–1.0036) | 0.832 |
| CK, U/L | 1.01(0.99–1.04) | 0.335 |
| CKMB, ng/mL | 0.95(0.83–1.060 | 0.415 |
| hsTn T, ng/L | 1.00(0.9953–1.0026) | 0.652 |
| NT-proBNP, pg/mL | 1.00(0.9981–1.0059) | 0.554 |
| Multivessel disease, yes vs no | 5.54(3.33–9.46) | <0.001 |
| Calcified lesions, yes vs no | 1.7(1.10–2.63) | 0.016 |
| Bifurcation lesions, yes vs no | 1.89(1.18–3.07) | <0.05 |
| Ostial lesions, yes vs no | 0.63(0.29–1.34) | 0.241 |
| Angular distortion | 0.93(0.25–3.50) | 0.917 |
| Lesions, yes vs no | ||
| Target LM, yes vs no | 1.30(0.46–3.75) | 0.611 |
| Target LAD, yes vs no | 0.45(0.29–0.73) | 0.059 |
| Target LCX, yes vs no | 0.65(0.44–0.96) | 0.086 |
| Target RCA, yes vs no | 0.57(0.37–0.87) | 0.072 |
| Emergency PCI, yes vs no | 1.96(0.98–3.93) | 0.057 |
| CTO, yes vs no | 2.66(1.48–4.91) | <0.01 |
| Number of stents implanted | 1.19(0.79–1.80) | 0.393 |
| Stent length, mm | 1.00(0.99–1.01) | 0.917 |
| Stent diameter, mm | 0.62(0.40–0.97) | 0.056 |
| IVUS, yes vs no | 0.88(0.25–2.97) | 0.838 |
Abbreviations: DM, diabetes mellitus; CHD, Coronary heart disease; MI, Myocardial infarction; TIA, transient ischemic attack; FBG, fasting blood glucose; SCr, serum creatinine; SUA, serum uric acid; TC, total cholesterol; Total cholesterol 2, Total cholesterol at re-admission; Triglyceride2, Triglyceride at re-admission; HDL, High density lipoprotein cholesterol; HDL2, High density lipoprotein cholesterol at re-admission; LDL, Low Density Lipoprotein cholesterol; LDL2, Low Density Lipoprotein cholesterol at re-admission; Lp(a), Lipoprotein-a; WBC, white blood cell; NLR, Neutrophil-to-lymphocyte ratio; LDH, lactate dehydrogenase; CK, creatine kinase; CKMB, creatine kinase MB; hsTn T, Hypersensitive troponin T; NT-proBNP, N-terminal pro-brain natriuretic peptide; LM, left main coronary artery; LAD, left anterior descending coronary artery; LCX, left circumflex coronary artery; RCA, right coronary artery; PCI, Percutaneous coronary intervention; CTO, chronic total occlusion; IVUS, intravenous ultrasound.